Cargando…

USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation

The maintenance of genetic stability depends on the fine-tuned initiation and termination of pathways involved in cell cycle checkpoints and DNA repair. Here, we describe a new pathway that regulates checkpoint kinase 1 (CHK1) activity, a key element controlling both checkpoints and DNA repair. We s...

Descripción completa

Detalles Bibliográficos
Autores principales: Guervilly, Jean-Hugues, Renaud, Emilie, Takata, Minoru, Rosselli, Filippo
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090195/
https://www.ncbi.nlm.nih.gov/pubmed/21389083
http://dx.doi.org/10.1093/hmg/ddr103
_version_ 1782203123008274432
author Guervilly, Jean-Hugues
Renaud, Emilie
Takata, Minoru
Rosselli, Filippo
author_facet Guervilly, Jean-Hugues
Renaud, Emilie
Takata, Minoru
Rosselli, Filippo
author_sort Guervilly, Jean-Hugues
collection PubMed
description The maintenance of genetic stability depends on the fine-tuned initiation and termination of pathways involved in cell cycle checkpoints and DNA repair. Here, we describe a new pathway that regulates checkpoint kinase 1 (CHK1) activity, a key element controlling both checkpoints and DNA repair. We show that the ubiquitin-specific peptidase 1 (USP1) deubiquitinase participates in the maintenance of both total and phosphorylated levels of CHK1 in response to genotoxic stress. We establish that USP1 depletion stimulates the damage-specific DNA-binding protein 1-dependent degradation of phosphorylated CHK1 in both a monoubiquitinylated Fanconi anaemia, complementation group D2 (FANCD2)-dependent and -independent manner. Our data support the existence of a circuit in which CHK1 activates checkpoints, DNA repair and proliferating cell nuclear antigen and FANCD2 monoubiquitinylation. The latter two events, in turn, switch off activated CHK1 by negative feedback inhibition, which contributes to the downregulation of the DNA damage response. This pathway, which is compromised in the cancer-prone disease Fanconi anaemia (FA), likely contributes to the hypersensitivity of cells from FA patients to DNA damage and to the clinical phenotype of the syndrome; it may also represent a pharmacological target to improve patient care and develop new cancer therapies.
format Text
id pubmed-3090195
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-30901952011-05-10 USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation Guervilly, Jean-Hugues Renaud, Emilie Takata, Minoru Rosselli, Filippo Hum Mol Genet Articles The maintenance of genetic stability depends on the fine-tuned initiation and termination of pathways involved in cell cycle checkpoints and DNA repair. Here, we describe a new pathway that regulates checkpoint kinase 1 (CHK1) activity, a key element controlling both checkpoints and DNA repair. We show that the ubiquitin-specific peptidase 1 (USP1) deubiquitinase participates in the maintenance of both total and phosphorylated levels of CHK1 in response to genotoxic stress. We establish that USP1 depletion stimulates the damage-specific DNA-binding protein 1-dependent degradation of phosphorylated CHK1 in both a monoubiquitinylated Fanconi anaemia, complementation group D2 (FANCD2)-dependent and -independent manner. Our data support the existence of a circuit in which CHK1 activates checkpoints, DNA repair and proliferating cell nuclear antigen and FANCD2 monoubiquitinylation. The latter two events, in turn, switch off activated CHK1 by negative feedback inhibition, which contributes to the downregulation of the DNA damage response. This pathway, which is compromised in the cancer-prone disease Fanconi anaemia (FA), likely contributes to the hypersensitivity of cells from FA patients to DNA damage and to the clinical phenotype of the syndrome; it may also represent a pharmacological target to improve patient care and develop new cancer therapies. Oxford University Press 2011-06-01 2011-03-09 /pmc/articles/PMC3090195/ /pubmed/21389083 http://dx.doi.org/10.1093/hmg/ddr103 Text en © The Author 2011. Published by Oxford University Press http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Guervilly, Jean-Hugues
Renaud, Emilie
Takata, Minoru
Rosselli, Filippo
USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
title USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
title_full USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
title_fullStr USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
title_full_unstemmed USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
title_short USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
title_sort usp1 deubiquitinase maintains phosphorylated chk1 by limiting its ddb1-dependent degradation
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090195/
https://www.ncbi.nlm.nih.gov/pubmed/21389083
http://dx.doi.org/10.1093/hmg/ddr103
work_keys_str_mv AT guervillyjeanhugues usp1deubiquitinasemaintainsphosphorylatedchk1bylimitingitsddb1dependentdegradation
AT renaudemilie usp1deubiquitinasemaintainsphosphorylatedchk1bylimitingitsddb1dependentdegradation
AT takataminoru usp1deubiquitinasemaintainsphosphorylatedchk1bylimitingitsddb1dependentdegradation
AT rossellifilippo usp1deubiquitinasemaintainsphosphorylatedchk1bylimitingitsddb1dependentdegradation